---
document_datetime: 2023-09-21 19:31:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/savene-epar-all-authorised-presentations_en.pdf
document_name: savene-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6409248
conversion_datetime: 2025-12-28 02:52:42.934981
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                                          | Route of Administration   | Immediate Packaging                  | Content (concentration)                        | Pack size            |
|------------------|-------------------|------------|--------------------------------------------------------------|---------------------------|--------------------------------------|------------------------------------------------|----------------------|
| EU/1/06/350/001  | Savene            | 20 mg/ml   | Powder and solvent for concentrate for solution for infusion | Intravenous use           | powder: vial (glass); bottle (glass) | concentrate: 25 ml (20 mg/ml); diluent: 500 ml | 10 vials + 3 bottles |